KLK3 and neoplasm: Few studies have been reported regarding clinical use of artesunate in cancer, but artesunate has demonstrated anti-tumor effects in a small randomized clinical trial in colon cancer and to transiently decrease tumor size and prostate-specific antigen levels in a patient with advanced prostate cancer [9, 10].